I. Szabo et al., SUPPRESSION OF PERITONEAL MACROPHAGE PHAGOCYTOSIS OF CANDIDA-ALBICANSBY OPIOIDS, The Journal of pharmacology and experimental therapeutics, 267(2), 1993, pp. 703-706
Receptor-selective opioid agonists have been found to suppress the cap
acity of macrophages to ingest opsonized sheep erythrocytes. In an eff
ort to characterize the immunomodulatory activity of opioids further,
experiments were done to examine the uptake of Candida albicans by opi
oid-treated murine peritoneal macrophages. It was found that treatment
with morphine and selective mu, i.e., DAMGO, delta, i.e., DPDPE, and
kappa, i.e., trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl) cyclohe
xyl]benzene-acetamide methanesulfonate, receptor agonists resulted a c
oncentration-dependent suppression of both the percentage of phagocyti
c cells and the average number of ingested yeasts. Antagonists selecti
ve for mu, i.e., H-D-Phe-Cys-Tyr-o-Trp-Arg-Thr-Pen-Thr-NH2, delta, i.e
., naltrindole, and kappa, i.e., norbinaltorphimine, opioid receptors
completely blocked the respective receptor-selective agonist-induced s
uppression. These results suggest that the mu, delta and kappa opioid
receptors can modulate macrophage function.